Click for best price
Pediatric Orphan Drugs Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Pediatric Orphan Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Orphan Drugs. This report contains market size and forecasts of Pediatric Orphan Drugs in global, including the following market information:
Global Pediatric Orphan Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Pediatric Orphan Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Oncology Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pediatric Orphan Drugs include Recordati SpA, Novartis, Celgene, Abbvie Inc., Orpharma, Amgen Inc., Amryt Pharma Plc., Johnson & Johnson and GSK Plc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pediatric Orphan Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pediatric Orphan Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Pediatric Orphan Drugs Market Segment Percentages, by Type, 2022 (%)
Oncology Drugs
Gastrointestinal Drugs
Neurology Drugs
Cardio-vascular Drugs
Others
Global Pediatric Orphan Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Pediatric Orphan Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail pharmacies
Others
Global Pediatric Orphan Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Pediatric Orphan Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pediatric Orphan Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Pediatric Orphan Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Recordati SpA
Novartis
Celgene
Abbvie Inc.
Orpharma
Amgen Inc.
Amryt Pharma Plc.
Johnson & Johnson
GSK Plc.
Bristol-Myers Squibb Company
Roche Holding
Pfizer
Sanofi
Takeda
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pediatric Orphan Drugs, market overview.
Chapter 2: Global Pediatric Orphan Drugs market size in revenue.
Chapter 3: Detailed analysis of Pediatric Orphan Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pediatric Orphan Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Pediatric Orphan Drugs Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pediatric Orphan Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pediatric Orphan Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pediatric Orphan Drugs Overall Market Size
2.1 Global Pediatric Orphan Drugs Market Size: 2022 VS 2030
2.2 Global Pediatric Orphan Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pediatric Orphan Drugs Players in Global Market
3.2 Top Global Pediatric Orphan Drugs Companies Ranked by Revenue
3.3 Global Pediatric Orphan Drugs Revenue by Companies
3.4 Top 3 and Top 5 Pediatric Orphan Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Pediatric Orphan Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pediatric Orphan Drugs Players in Global Market
3.6.1 List of Global Tier 1 Pediatric Orphan Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Pediatric Orphan Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pediatric Orphan Drugs Market Size Markets, 2022 & 2030
4.1.2 Oncology Drugs
4.1.3 Gastrointestinal Drugs
4.1.4 Neurology Drugs
4.1.5 Cardio-vascular Drugs
4.1.6 Others
4.2 By Type - Global Pediatric Orphan Drugs Revenue & Forecasts
4.2.1 By Type - Global Pediatric Orphan Drugs Revenue, 2018-2023
4.2.2 By Type - Global Pediatric Orphan Drugs Revenue, 2024-2030
4.2.3 By Type - Global Pediatric Orphan Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pediatric Orphan Drugs Market Size, 2022 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Retail pharmacies
5.1.4 Others
5.2 By Application - Global Pediatric Orphan Drugs Revenue & Forecasts
5.2.1 By Application - Global Pediatric Orphan Drugs Revenue, 2018-2023
5.2.2 By Application - Global Pediatric Orphan Drugs Revenue, 2024-2030
5.2.3 By Application - Global Pediatric Orphan Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Pediatric Orphan Drugs Market Size, 2022 & 2030
6.2 By Region - Global Pediatric Orphan Drugs Revenue & Forecasts
6.2.1 By Region - Global Pediatric Orphan Drugs Revenue, 2018-2023
6.2.2 By Region - Global Pediatric Orphan Drugs Revenue, 2024-2030
6.2.3 By Region - Global Pediatric Orphan Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Pediatric Orphan Drugs Revenue, 2018-2030
6.3.2 US Pediatric Orphan Drugs Market Size, 2018-2030
6.3.3 Canada Pediatric Orphan Drugs Market Size, 2018-2030
6.3.4 Mexico Pediatric Orphan Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Pediatric Orphan Drugs Revenue, 2018-2030
6.4.2 Germany Pediatric Orphan Drugs Market Size, 2018-2030
6.4.3 France Pediatric Orphan Drugs Market Size, 2018-2030
6.4.4 U.K. Pediatric Orphan Drugs Market Size, 2018-2030
6.4.5 Italy Pediatric Orphan Drugs Market Size, 2018-2030
6.4.6 Russia Pediatric Orphan Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Pediatric Orphan Drugs Market Size, 2018-2030
6.4.8 Benelux Pediatric Orphan Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Pediatric Orphan Drugs Revenue, 2018-2030
6.5.2 China Pediatric Orphan Drugs Market Size, 2018-2030
6.5.3 Japan Pediatric Orphan Drugs Market Size, 2018-2030
6.5.4 South Korea Pediatric Orphan Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Pediatric Orphan Drugs Market Size, 2018-2030
6.5.6 India Pediatric Orphan Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Pediatric Orphan Drugs Revenue, 2018-2030
6.6.2 Brazil Pediatric Orphan Drugs Market Size, 2018-2030
6.6.3 Argentina Pediatric Orphan Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pediatric Orphan Drugs Revenue, 2018-2030
6.7.2 Turkey Pediatric Orphan Drugs Market Size, 2018-2030
6.7.3 Israel Pediatric Orphan Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Pediatric Orphan Drugs Market Size, 2018-2030
6.7.5 UAE Pediatric Orphan Drugs Market Size, 2018-2030
7 Pediatric Orphan Drugs Companies Profiles
7.1 Recordati SpA
7.1.1 Recordati SpA Company Summary
7.1.2 Recordati SpA Business Overview
7.1.3 Recordati SpA Pediatric Orphan Drugs Major Product Offerings
7.1.4 Recordati SpA Pediatric Orphan Drugs Revenue in Global Market (2018-2023)
7.1.5 Recordati SpA Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Pediatric Orphan Drugs Major Product Offerings
7.2.4 Novartis Pediatric Orphan Drugs Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Celgene
7.3.1 Celgene Company Summary
7.3.2 Celgene Business Overview
7.3.3 Celgene Pediatric Orphan Drugs Major Product Offerings
7.3.4 Celgene Pediatric Orphan Drugs Revenue in Global Market (2018-2023)
7.3.5 Celgene Key News & Latest Developments
7.4 Abbvie Inc.
7.4.1 Abbvie Inc. Company Summary
7.4.2 Abbvie Inc. Business Overview
7.4.3 Abbvie Inc. Pediatric Orphan Drugs Major Product Offerings
7.4.4 Abbvie Inc. Pediatric Orphan Drugs Revenue in Global Market (2018-2023)
7.4.5 Abbvie Inc. Key News & Latest Developments
7.5 Orpharma
7.5.1 Orpharma Company Summary
7.5.2 Orpharma Business Overview
7.5.3 Orpharma Pediatric Orphan Drugs Major Product Offerings
7.5.4 Orpharma Pediatric Orphan Drugs Revenue in Global Market (2018-2023)
7.5.5 Orpharma Key News & Latest Developments
7.6 Amgen Inc.
7.6.1 Amgen Inc. Company Summary
7.6.2 Amgen Inc. Business Overview
7.6.3 Amgen Inc. Pediatric Orphan Drugs Major Product Offerings
7.6.4 Amgen Inc. Pediatric Orphan Drugs Revenue in Global Market (2018-2023)
7.6.5 Amgen Inc. Key News & Latest Developments
7.7 Amryt Pharma Plc.
7.7.1 Amryt Pharma Plc. Company Summary
7.7.2 Amryt Pharma Plc. Business Overview
7.7.3 Amryt Pharma Plc. Pediatric Orphan Drugs Major Product Offerings
7.7.4 Amryt Pharma Plc. Pediatric Orphan Drugs Revenue in Global Market (2018-2023)
7.7.5 Amryt Pharma Plc. Key News & Latest Developments
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Company Summary
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Pediatric Orphan Drugs Major Product Offerings
7.8.4 Johnson & Johnson Pediatric Orphan Drugs Revenue in Global Market (2018-2023)
7.8.5 Johnson & Johnson Key News & Latest Developments
7.9 GSK Plc.
7.9.1 GSK Plc. Company Summary
7.9.2 GSK Plc. Business Overview
7.9.3 GSK Plc. Pediatric Orphan Drugs Major Product Offerings
7.9.4 GSK Plc. Pediatric Orphan Drugs Revenue in Global Market (2018-2023)
7.9.5 GSK Plc. Key News & Latest Developments
7.10 Bristol-Myers Squibb Company
7.10.1 Bristol-Myers Squibb Company Company Summary
7.10.2 Bristol-Myers Squibb Company Business Overview
7.10.3 Bristol-Myers Squibb Company Pediatric Orphan Drugs Major Product Offerings
7.10.4 Bristol-Myers Squibb Company Pediatric Orphan Drugs Revenue in Global Market (2018-2023)
7.10.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.11 Roche Holding
7.11.1 Roche Holding Company Summary
7.11.2 Roche Holding Business Overview
7.11.3 Roche Holding Pediatric Orphan Drugs Major Product Offerings
7.11.4 Roche Holding Pediatric Orphan Drugs Revenue in Global Market (2018-2023)
7.11.5 Roche Holding Key News & Latest Developments
7.12 Pfizer
7.12.1 Pfizer Company Summary
7.12.2 Pfizer Business Overview
7.12.3 Pfizer Pediatric Orphan Drugs Major Product Offerings
7.12.4 Pfizer Pediatric Orphan Drugs Revenue in Global Market (2018-2023)
7.12.5 Pfizer Key News & Latest Developments
7.13 Sanofi
7.13.1 Sanofi Company Summary
7.13.2 Sanofi Business Overview
7.13.3 Sanofi Pediatric Orphan Drugs Major Product Offerings
7.13.4 Sanofi Pediatric Orphan Drugs Revenue in Global Market (2018-2023)
7.13.5 Sanofi Key News & Latest Developments
7.14 Takeda
7.14.1 Takeda Company Summary
7.14.2 Takeda Business Overview
7.14.3 Takeda Pediatric Orphan Drugs Major Product Offerings
7.14.4 Takeda Pediatric Orphan Drugs Revenue in Global Market (2018-2023)
7.14.5 Takeda Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Pediatric Orphan Drugs Market Opportunities & Trends in Global Market
Table 2. Pediatric Orphan Drugs Market Drivers in Global Market
Table 3. Pediatric Orphan Drugs Market Restraints in Global Market
Table 4. Key Players of Pediatric Orphan Drugs in Global Market
Table 5. Top Pediatric Orphan Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Pediatric Orphan Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Pediatric Orphan Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Pediatric Orphan Drugs Product Type
Table 9. List of Global Tier 1 Pediatric Orphan Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pediatric Orphan Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Pediatric Orphan Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Pediatric Orphan Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Pediatric Orphan Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Pediatric Orphan Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Pediatric Orphan Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Pediatric Orphan Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Pediatric Orphan Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Pediatric Orphan Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Pediatric Orphan Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Pediatric Orphan Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Pediatric Orphan Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Pediatric Orphan Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Pediatric Orphan Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Pediatric Orphan Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Recordati SpA Company Summary
Table 31. Recordati SpA Pediatric Orphan Drugs Product Offerings
Table 32. Recordati SpA Pediatric Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Recordati SpA Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Pediatric Orphan Drugs Product Offerings
Table 36. Novartis Pediatric Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. Celgene Company Summary
Table 39. Celgene Pediatric Orphan Drugs Product Offerings
Table 40. Celgene Pediatric Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Celgene Key News & Latest Developments
Table 42. Abbvie Inc. Company Summary
Table 43. Abbvie Inc. Pediatric Orphan Drugs Product Offerings
Table 44. Abbvie Inc. Pediatric Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Abbvie Inc. Key News & Latest Developments
Table 46. Orpharma Company Summary
Table 47. Orpharma Pediatric Orphan Drugs Product Offerings
Table 48. Orpharma Pediatric Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Orpharma Key News & Latest Developments
Table 50. Amgen Inc. Company Summary
Table 51. Amgen Inc. Pediatric Orphan Drugs Product Offerings
Table 52. Amgen Inc. Pediatric Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Amgen Inc. Key News & Latest Developments
Table 54. Amryt Pharma Plc. Company Summary
Table 55. Amryt Pharma Plc. Pediatric Orphan Drugs Product Offerings
Table 56. Amryt Pharma Plc. Pediatric Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Amryt Pharma Plc. Key News & Latest Developments
Table 58. Johnson & Johnson Company Summary
Table 59. Johnson & Johnson Pediatric Orphan Drugs Product Offerings
Table 60. Johnson & Johnson Pediatric Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Johnson & Johnson Key News & Latest Developments
Table 62. GSK Plc. Company Summary
Table 63. GSK Plc. Pediatric Orphan Drugs Product Offerings
Table 64. GSK Plc. Pediatric Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. GSK Plc. Key News & Latest Developments
Table 66. Bristol-Myers Squibb Company Company Summary
Table 67. Bristol-Myers Squibb Company Pediatric Orphan Drugs Product Offerings
Table 68. Bristol-Myers Squibb Company Pediatric Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Bristol-Myers Squibb Company Key News & Latest Developments
Table 70. Roche Holding Company Summary
Table 71. Roche Holding Pediatric Orphan Drugs Product Offerings
Table 72. Roche Holding Pediatric Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Roche Holding Key News & Latest Developments
Table 74. Pfizer Company Summary
Table 75. Pfizer Pediatric Orphan Drugs Product Offerings
Table 76. Pfizer Pediatric Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Pfizer Key News & Latest Developments
Table 78. Sanofi Company Summary
Table 79. Sanofi Pediatric Orphan Drugs Product Offerings
Table 80. Sanofi Pediatric Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Sanofi Key News & Latest Developments
Table 82. Takeda Company Summary
Table 83. Takeda Pediatric Orphan Drugs Product Offerings
Table 84. Takeda Pediatric Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. Takeda Key News & Latest Developments
List of Figures
Figure 1. Pediatric Orphan Drugs Segment by Type in 2022
Figure 2. Pediatric Orphan Drugs Segment by Application in 2022
Figure 3. Global Pediatric Orphan Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pediatric Orphan Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Pediatric Orphan Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pediatric Orphan Drugs Revenue in 2022
Figure 8. By Type - Global Pediatric Orphan Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Pediatric Orphan Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Pediatric Orphan Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Pediatric Orphan Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Pediatric Orphan Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Pediatric Orphan Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Pediatric Orphan Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Pediatric Orphan Drugs Revenue Market Share, 2018-2030
Figure 16. US Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Pediatric Orphan Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Pediatric Orphan Drugs Revenue Market Share, 2018-2030
Figure 28. China Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Pediatric Orphan Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Pediatric Orphan Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Pediatric Orphan Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Recordati SpA Pediatric Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Pediatric Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Celgene Pediatric Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Abbvie Inc. Pediatric Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Orpharma Pediatric Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Amgen Inc. Pediatric Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Amryt Pharma Plc. Pediatric Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Johnson & Johnson Pediatric Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. GSK Plc. Pediatric Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Bristol-Myers Squibb Company Pediatric Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Roche Holding Pediatric Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Pfizer Pediatric Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Sanofi Pediatric Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Takeda Pediatric Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
